Moreover, a Chinese herbal formula inhibits inflammatory cytokines (TNF-α, IL-6, and IL-1β) through IL-17, HIF-1α, and TNF-α signaling pathways, exerting anti-inflammatory effects in SS patients and providing a theoretical basis for its clinical application (198). This evidence concerns the gene IL17A and synovial sarcoma.